Improving assessment in small fiber neuropathy

Journal of the Peripheral Nervous System

Volumn 20, Issue 3, 2015, Pages 333-340

  Brouwer, Brigitte A ^a   Bakkers, Mayienne ^a   Hoeijmakers, Janneke G J ^a   Faber, Catharina G ^a   Merkies, Ingemar S J ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b N   (Netherlands)

Author keywords

outcome research; peripheral neuropathy; Rasch built overall disability scale; small fiber neuropathy

Indexed keywords

ADULT; AGED; ARTICLE; BURNING FEET SYNDROME; DISCRIMINATIVE VALIDITY; FEMALE; FUNCTIONAL STATUS ASSESSMENT; HOT FLUSH; HUMAN; INTERNAL RELIABILITY; MAJOR CLINICAL STUDY; MALE; PAIN INTENSITY; PAIN SEVERITY; PRIORITY JOURNAL; QUESTIONNAIRE; RASCH ANALYSIS; RASCH BUILT OVERALL DISABILITY SCALE; RELIABILITY; SKIN SENSITIVITY; SMALL FIBER NEUROPATHY; SYMPTOMS INVENTORY QUESTIONNAIRE; TEST RETEST RELIABILITY; TREND STUDY; VALIDITY; VISUAL ANALOG SCALE; COHORT ANALYSIS; DISABLED PERSON; ERYTHROMELALGIA; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PROCEDURES; PSYCHOMETRY; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; DISABLED PERSONS; ERYTHROMELALGIA; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 84942605687     PISSN: 10859489     EISSN: 15298027     Source Type: Journal    
DOI: 10.1111/jns.12128     Document Type: Article

References (34)

1. Amir R, Argoff CE, Bennett GJ, Cummins TR, Durieux ME, Gerner P, Gold MS, Porreca F, Strichartz GR, (2006). The role of sodium channels in chronic inflammatory and neuropathic pain. J Pain 7: S1-S29.
2. Andrich D, Sheridan B, Luo G, (2010). Rasch Models for Measurement: RUMM2030. RUMM Laboratory, Perth.
3. Bakkers M, Merkies IS, Lauria G, Devigili G, Penza P, Lombardi R, Hermans MC, van Nes SI, De Baets M, Faber CG, (2009). Intraepidermal nerve fiber density and its application in sarcoidosis. Neurology 73: 1142-1148.
4. Bakkers M, Faber CG, Hoeijmakers JG, Lauria G, Merkies IS, (2014). Small fibers, large impact: quality of life in small-fiber neuropathy. Muscle Nerve 49: 329-336.
5. Bland JM, Altman DG, (1995). Multiple significance tests: the Bonferroni method. BMJ 310: 170.
6. DeVellis RF, (2006). Classical test theory. Med Care 44: S50-S59.
7. Dworkin RH, Turk DC, McDermott MP, Peirce-Sandner S, Burke LB, Cowan P, Farrar JT, Hertz S, Raja SN, Rappaport BA, Rauschkolb C, Sampaio C, (2009). Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain 146: 238-244.
8. Faber CG, Hoeijmakers JG, Ahn HS, Cheng X, Han C, Choi JS, Estacion M, Lauria G, Vanhoutte EK, Gerrits MM, Dib-Hajj S, Drenth JP, Waxman SG, Merkies IS, (2012a). Gain of function Na(v)1.7 mutations in idiopathic small fiber neuropathy. Ann Neurol 71: 26-39.
9. Faber CG, Lauria G, Merkies IS, Cheng X, Han C, Ahn HS, Persson AK, Hoeijmakers JG, Gerrits MM, Pierro T, Lombardi R, Kapetis D, Dib-Hajj SD, Waxman SG, (2012b). Gain-of-function Nav1.8 mutations in painful neuropathy. Proc Natl Acad Sci U S A 109: 19444-19449.
10. Fisher WP, (1992). Reliability statistics. Rasch Meas Transact 6: 238.
11. Hoeijmakers JG, Faber CG, Lauria G, Merkies IS, Waxman SG, (2012). Small-fibre neuropathies - advances in diagnosis, pathophysiology and management. Nat Rev Neurol 8: 369-379.
12. Huang J, Han C, Estacion M, Vasylyev D, Hoeijmakers JG, Gerrits MM, Tyrrell L, Lauria G, Faber CG, Dib-Hajj SD, Merkies IS, Waxman SG, Study Group P, (2014). Gain-of-function mutations in sodium channel Na(v)1.9 in painful neuropathy. Brain 137: 1627-1642.
13. Lai J, Hunter JC, Porreca F, (2003). The role of voltage-gated sodium channels in neuropathic pain. Curr Opin Neurobiol 13: 291-297.
14. Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, Devigili G, Smith AG, Hsieh ST, Mellgren SI, Umapathi T, Ziegler D, Faber CG, Merkies IS, (2010a). Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 15: 202-207.
15. Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI, Nolano M, Merkies IS, Polydefkis M, Smith AG, Sommer C, Valls-Sole J, (2010b). European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 17: 903-912 e44-e49.
16. Lauria G, Merkies IS, Faber CG, (2012). Small fibre neuropathy. Curr Opin Neurol 25: 542-549.
17. Liang MH, (1995). Evaluating measurement responsiveness. J Rheumatol 22: 1191-1192.
18. Maxwell C, (1978). Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment. Br J Clin Pharmacol 6: 15-24.
19. Merbitz C, Morris J, Grip JC, (1989). Ordinal scales and foundations of misinference. Arch Phys Med Rehabil 70: 308-312.
20. Merkies IS, Lauria G, Faber CG, (2012). Outcome measures in peripheral neuropathies: requirements through statements. Curr Opin Neurol 25: 556-563.
21. van Nes SI, Vanhoutte EK, van Doorn PA, Hermans M, Bakkers M, Kuitwaard K, Faber CG, Merkies IS, (2011). Rasch-built overall disability scale (R-ODS) for immune-mediated peripheral neuropathies. Neurology 76: 337-345.
22. Pallant JF, Tennant A, (2007). An introduction to the Rasch measurement model: an example using the Hospital Anxiety and Depression Scale (HADS). Br J Clin Psychol 46: 1-18.
23. Peters MJ, Bakkers M, Merkies IS, Hoeijmakers JG, van Raak EP, Faber CG, (2013). Incidence and prevalence of small-fiber neuropathy: a survey in the Netherlands. Neurology 81: 1356-1360.
24. Poliakov I, Toth C, (2011). The impact of pain in patients with polyneuropathy. Eur J Pain 15: 1015-1022.
25. Rasch G, (1960). Probabilistic Models for Some Intelligence and Attainment Tests. University of Chicago Press, Chicago.
26. Streiner DL, Norman GR, (1998). Health Measurement Scales. A Practical Guide to their Development and Use. Oxford University Press, New York.
27. Tennant A, Conaghan PG, (2007). The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper? Arthritis Rheum 57: 1358-1362.
28. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P, (2010). Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33: 2285-2293.
29. Wang L, Hilliges M, Jernberg T, Wiegleb-Edstrom D, Johansson O, (1990). Protein gene product 9.5-immunoreactive nerve fibres and cells in human skin. Cell Tissue Res 261: 25-33.
30. Ware JE, Kosinski M, Gandek B, (2000). SF-36VR Health Survey. Manual and Interpretation Guide. RAND Corporation, Santa Monica.
31. World Health Organization (2001). The International Classification of Functioning, Disability and Health. World Health Organization, Geneva.
32. Wright BD, Linacre JM, (1989). Observations are always ordinal; measurements, however, must be interval. Arch Phys Med Rehabil 70: 857-860.
33. Wright BD, Stone MH, (1979). Best Test Design. Media Press, Chicago.
34. Yarnitsky D, Sprecher E, (1994). Thermal testing: normative data and repeatability for various test algorithms. J Neurol Sci 125: 39-45.